Medicines labeled for the same conditions
Alternatives to cefoxitin
27 other medicines are given the same way (intravenous) and in the same FDA class as cefoxitin or labeled mainly for the same use (bacterial infections); 10 are in its class, cephalosporin antibacterials: cefazolin, cefepime, ceftriaxone, cefuroxime and 6 more; the others include 2 beta lactamase inhibitors, 2 fluoroquinolone antibacterials and 2 penicillin-class antibacterials (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $1.07 per cefazolin 1 g vial (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as cefoxitin?
The first 24 of the 27, the same class first. Bacterial infections lists all 51 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (intravenous) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Cefoxitincephalosporin antibacterial | this medicine | 5 labelers | n/a | No | No current entry |
| Cefazolincephalosporin antibacterial · same class | Urinary tract infections | 7 labelers | $1.07 per vial 1 g vial | No | No current entry |
| Cefepimecephalosporin antibacterial · same class | Urinary tract infections | 8 labelers | n/a | No | A presentation being discontinued |
| Ceftriaxonecephalosporin antibacterial · same class | Bacterial infections, Urinary tract infections | 7 labelers | $1.44 per vial 1 g vial | No | No current entry |
| Cefuroximecephalosporin antibacterial · same class | Bacterial infections, Urinary tract infections | 2 labelers | n/a | No | No current entry |
| Ceftazidimecephalosporin antibacterial · same class | Bacterial infections | 3 labelers | $3.70 per vial 1 g vial | No | A presentation being discontinued |
| Avibactam and ceftazidimebeta lactamase inhibitor · same class | Urinary tract infections | none listed | n/a | No | No current entry |
| Cefepime and zidebactamcephalosporin antibacterial · same class | Urinary tract infections | none listed | n/a | No | No current entry |
| Cefiderocolcephalosporin antibacterial · same class | Urinary tract infections | none listed | n/a | No | No current entry |
| Cefotaximecephalosporin antibacterial · same class | Bacterial infections | 1 labeler | n/a | No | In shortage |
| Ceftolozane and tazobactambeta lactamase inhibitor · same class | Urinary tract infections | none listed | n/a | No | No current entry |
| Vancomycinglycopeptide antibacterial | Bacterial infections | 21 labelers | $2.31 per vial 500 mg vial | No | A presentation being discontinued |
| Piperacillin and tazobactambeta lactamase inhibitor | Bacterial infections | 15 labelers | $3.49 per vial 3.375 g vial | No | A presentation being discontinued |
| Levofloxacinfluoroquinolone antibacterial | Bacterial infections, Urinary tract infections | 8 labelers | n/a | Yes | No current entry |
| Clindamycinlincosamide antibacterial | Bacterial infections | 6 labelers | n/a | Yes | In shortage |
| Ampicillinpenicillin-class antibacterial | Bacterial infections, Urinary tract infections | 11 labelers | n/a | No | A presentation being discontinued |
| Linezolidoxazolidinone antibacterial | Bacterial infections | 9 labelers | n/a | No | No current entry |
| Ampicillin and sulbactambeta lactamase inhibitor | Bacterial infections | 7 labelers | n/a | No | No current entry |
| Azithromycinmacrolide antimicrobial | Bacterial infections | 7 labelers | n/a | No | A presentation being discontinued |
| Metronidazolenitroimidazole antimicrobial | Bacterial infections | 7 labelers | n/a | Yes | In shortage |
| Tobramycinaminoglycoside antibacterial | Bacterial infections, Urinary tract infections | 7 labelers | $0.832 per mL 80 mg/2 mL vial | No | A presentation being discontinued |
| Penicillin gpenicillin-class antibacterial | Bacterial infections | 6 labelers | n/a | No | No current entry |
| Tigecyclinetetracycline-class antibacterial | Bacterial infections | 4 labelers | n/a | Yes | No current entry |
| Sulfamethoxazole and trimethoprimsulfonamide antimicrobial | Bacterial infections, Urinary tract infections | 2 labelers | n/a | No | No current entry |
| Gentamicinaminoglycoside antibacterial | Bacterial infections | 1 labeler | $1.30 per mL 80 mg/2 mL vial | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Cefoxitin: the full record
- label, generics, price, shortages, recalls
- Cefoxitin vs cefazolin
- two records side by side
- Cefoxitin vs ceftriaxone
- two records side by side
- Cefoxitin vs cefuroxime
- two records side by side